3 ms·
Vaccine risks tend to be very quickly detectable. The phase three trial timing was driven by needing enough infections and there weren't enough.
by wbl 2y ago
Vaccine risks tend to be very quickly detectable. The phase three trial timing was driven by needing enough infections and there weren't enough.
- _heimdall 2y agoTotally fair, by far the most common vaccine issues show up soon after injection. There is still the population challenge though. Dealing specifically with patients with multiple comorbidities and prescriptions would make it pretty tricky to recognize and then isolate the risk factors of anything that does show up. Strokes, heart attacks, circulatory issues, etc are likely pretty common in that population and any increase there after treatment may go unnoticed as a change. If you do recognize it they'd have to stop treatments entirely as you wouldn't know whether its a risk to everyone or specific to some combination of age, comorbidities, and/or other medications.
- wbl 2y agoThe nursing homes were charnal houses. You would need one hell of a stroke risk to make the vaccine not worth it. The andrenovirus vector clotting was fast appearing and rare enough continuing was worth it in elderly populations.